NeoGenomics Announced That Subsidiary Neogenomics Laboratories Will Appeal The Preliminary Injunction Issued By The U.S. District Court For The Middle District Of North Carolina

-3.07%

NeoGenomics, Inc.

NEO

7.26

-3.07%

The Initial Determination Is That Natera, Inc. Demonstrated A Likelihood That Products Using Radar Technology Infringe One Natera, Inc. Patent. The Order Specifically Allows Patients Already Using Radar To Continue Their Use. In Addition, The Order Explicitly Allows Research Projects And Studies That Are In Progress, As Well As Clinical Trials That Are In Progress Or Have Been Approved, To Continue.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.